Inferring tumour purity and stromal and immune cell admixture from expression data
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Yoshihara et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“We devised two gene signatures: (1) a ‘stromal signature’ that was designed to capture the presence of stroma in tumour tissue, and (2) an ‘immune signature’ that aimed to represent the infiltration of immune cells in tumour tissue (Supplementary Data 1).”
MethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cited by
Items 801–900 of 1,021
Roelands, J. P., Mall, R., Almeer, H., Thomas, R., Mohamed, M. G., Bedri, S. A., Al‐Bader, S. B., Junejo, K., Ziv, E., Sayaman, R. W., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00215-x · Cited by 48
Lalazar, G., Requena, D., Ramos-Espiritu, L. S., Ng, D., Bhola, P. D., de Jong, Y. P., Wang, R., Narayan, N. J. C., Shebl, B., Levin, S., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0872 · Cited by 49
“5 using DESeq2, excluding rRNA and mt-rRNA genes as well as the immune and stromal signature genes (47).”
MethodYan, K., Lu, Y., Yan, Z., & Wang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622563 · Cited by 50
“Using expression data to estimate stromal cells and immune cells in tumor tissues (ESTIMATE) (16), we evaluated the tumor purity of melanoma based on the ESTIMATE algorithm.”
MethodSun, J., Shi, R., Zhang, X., Fang, D., Rauch, J., Lu, S., Wang, X., Käsmann, L., Ma, J., Belka, C., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1964189 · Cited by 51
Chen, W., Lin, W., Wu, L., Xu, A., Liu, C., & Huang, P. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.69060 · Cited by 54
“The immune infiltration (immune score and stromal score) was assessed by the ESTIMATE algorithm [25], followed by analyzing the correlation of immune infiltration with risk score.”
MethodA Comprehensive Analysis of METTL1 to Immunity and Stemness in Pan-Cancer
Gao, Z., Xu, J., Zhang, Z., Yang, F., Xue, H., Guo, X. H., Deng, L., Wang, S., Zhao, R., Zhang, P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.795240 · Cited by 53
“org 3 to infer the degree of infiltration of stroma or immune cells into tumour based on RNA sequence profiles (25).”
BackgroundPan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune Evasion
Gong, X., & Karchin, R. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0886 · Cited by 47
A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes
Luo, Q., & Vögeli, T. (2020) · Cancers · doi:10.3390/cancers12103054 · Cited by 46
“The ESTIMATE scores also had a negative correlation with the tumor purity [62,63].”
BackgroundMethodChen, F., Jin, X., Han, Y., Guo, R., Zou, J., Li, Y., & Wang, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.926800 · Cited by 45
Tang, Y., Guo, C., Zhao, Y. C., Wang, Y., Zhang, Y., & Wang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862527 · Cited by 54
“The ESTIMATE algorithm was utilized to calculate the immune score, stromal score, estimate score, and tumor purity for all the patients in the TCGA-LIHC dataset (34, 35).”
MethodJohnson, A. L., Laterra, J., & López-Bertoni, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.995498 · Cited by 50
Shen, A., Ye, Y., Chen, F., Xu, Y., Zhang, Z., Zhao, Q., & Zeng, Z.-L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.969034 · Cited by 48
“First, we employed the “Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data” (ESTIMATE) algorithm (18), which scores each tumor sample for immune, stromal and tumor purity.”
MethodYang, H., Xu, H.-L., Wang, Z.-Y., Li, X., Wang, P., Cao, X.-L., Xu, Z.-Y., Lv, D., Rong, Y.-C., Chen, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110573 · Cited by 43
A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
Zhuang, L., Sun, Q., Huang, S., Hu, L., & Chen, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-30934-z · Cited by 47
Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis
Wu, X., Yan, H., Qiu, M., Qu, X., Wang, J., Xu, S., Zheng, Y., Ge, M., Yan, L., & Li, L. (2023) · eLife · doi:10.7554/elife.86032 · Cited by 54
Boesch, M., Onder, L., Cheng, H., Novković, M., Mörbe, U., Sopper, S., Gastl, G. A., Jochum, W., Ruhstaller, T., Knauer, M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1414129 · Cited by 46
Zhang, L., Chen, J., Cheng, T., Yang, H., Li, H., & Pan, C. (2020) · Journal of Cancer · doi:10.7150/jca.42531 · Cited by 45
Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer
Li, F., Teng, H., Liu, M., Liu, B., Zhang, D., Xu, Z., Wang, Y., & Zhou, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01302 · Cited by 45
“ESTIMATE algorithm is a newly developed method, which is used to predict the infiltration levels of non-tumor cells by analyzing their specific gene expression signature (13).”
MethodIdentification of prognosis-related genes in the cervical cancer immune microenvironment
Yang, L., Yang, Y., Meng, M., Wang, W., He, S., Zhao, Y., Gao, H., Tang, W., Liu, S., Lin, Z., et al. (2020) · Gene · doi:10.1016/j.gene.2020.145119 · Cited by 45
Uneda, A., Kurozumi, K., Fujimura, A., Fujii, K., Ishida, J., Shimazu, Y., Otani, Y., Tomita, Y., Hattori, Y., Matsumoto, Y., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01124-7 · Cited by 52
“Next, to predict the presence of stromal/immune cell populations in tumors and tumor purity, we used the ESTIMATE method [60].”
MethodAdditive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression
García‐Mulero, S., Alonso, M. H., del Carpio, L. P., Pamplona, R. S., & Piulats, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052669 · Cited by 46
“ESTIMATE is a tool that predicts the tumor purity and infiltrating stromal/immune cells from gene signatures [42].”
MethodMYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma
Raieli, S., Renzo, D. D., Lampis, S., Amadesi, C., Montemurro, L., Pession, A., Hrelia, P., Fischer, M., & Tonelli, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.625207 · Cited by 49
“We also confirmed with a different algorithm (50) that MYCN immune score is associated with low immune infiltration and high tumor purity (Figures S12A, B).”
ResultCen, S., Liu, K., Zheng, Y., Shan, J., Jing, C., Gao, J., Pan, H., Bai, Z., & Liu, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.705060 · Cited by 45
Lietz, C. E., Newman, E. T., Kelly, A. D., Xiang, D. H., Zhang, Z., Luscko, C. A., Lozano‐Calderón, S. A., Ebb, D. H., Raskin, K. A., Cote, G. M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03117-1 · Cited by 47
Song, J., Yang, R., Wei, R., Du, Y., He, P., & Liu, X. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00475-8 · Cited by 46
Lin, B., Zhang, T., Ye, X., & Yang, H. (2020) · Oncology Letters · doi:10.3892/ol.2020.11841 · Cited by 44
“The ‘ESTIMATE’ R package was used to predict the presence of infiltrating stromal/immune cells in tumor tissues using gene expression data (28).”
MethodA pan-cancer study of selenoprotein genes as promising targets for cancer therapy
Wu, W., Li, D., Feng, X., Zhao, F., Li, C., Zheng, S., & Lyu, J. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00930-1 · Cited by 52
“The stromal- and immune-cell scores calculated using the ESTIMATE algorithm were used to assess the level of invasion of stromal and immune cells in different tumor types [66, 67].”
MethodHe, R. L., Man, C., Huang, J., He, L., Wang, X., Lang, Y., & Fan, Y. J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.870945 · Cited by 46
Parmigiani, E., Ivánek, R., Rolando, C., Hafen, K., Turchinovich, G., Lehmann, F. M., Gerber, A., Brkić, Š., Frank, S., Meyer, S. C., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.06.006 · Cited by 48
Zou, R., Jiang, Q., Jin, T., Chen, M., Yao, L., & Ding, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956224 · Cited by 47
“A higher ESTIMATEScore indicates poorer tumor purity (25).”
BackgroundDevelopment of a copper metabolism-related gene signature in lung adenocarcinoma
Chang, W., Li, H., Zhong, L., Zhu, T., Chang, Z.-H., Ou, W., & Wang, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1040668 · Cited by 50
“Then, the tumor purity and TME score (including ESTIMATE score, immune score and stromal score) of each patient were estimated using the “estimate” package (23).”
MethodWei, Q., Jiang, X., Miao, X., Zhang, Y., Chen, F., & Zhang, P. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05000-w · Cited by 51
Liu, Z., Ding, M., Qiu, P., Pan, K., & Guo, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200282 · Cited by 46
“Estimation of Stromal and Immune cells in Malignant Tumor tissues using expression (ESTIMATE) algorithm was performed to analyze the proportion of the immune-stromal component in TIME by means of the “ estimate ” package in R software (31).”
Maimaiti, A., Turhon, M., Abulaiti, A., Dilixiati, Y., Zhang, F., Axier, A., Kadeer, K., Zhang, Y., Maimaitili, A., & Yang, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04512-w · Cited by 49
“The abundance of infiltrates of different immune cells between UIA and RIA groups was explored through the use of four different algorithms, namely EPIC algorithm, Microenvironmental Cell Population Counter (MCP Counter) algorithm [39], CIBERSORTabs, and the ESTIMATE algorithm [40].”
MethodTaraborrelli, L., Şenbabaoğlu, Y., Wang, L., Lim, J., Blake, K., Kljavin, N. M., Gierke, S., Scherl, A., Ziai, J. M., McNamara, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41618-7 · Cited by 47
“ATG16L1 expressionshoweda positive correlation with tumor epithelial signatures and negative correlations with immune and stromal signatures 36,37 , suggesting that the primary source of ATG16L1 expression was tumor cells (Fig.”
Lin, G., Gao, Z., Wu, S., Zheng, J., Guo, X., Zheng, X., & Chen, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-54135-4 · Cited by 49
“ESTIMATE algorithm 52 , obtaining public website (https:// sourc eforge. net/ proje cts/ estim atepr oject/), used to estimate StromalScore and ImmuneScore based on specific biomarkers associated with stromal cell and immune cell infiltration in tumor samples.”
MethodZhao, S., Zhang, P., Niu, S., Xie, J., Liu, Y., Liu, Y., Zhao, N., Cheng, C., & Lu, P. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01356-5 · Cited by 47
“The estimation of tumor mesenchymal and immune cell abundances, as well as tumor purity in colorectal cancer, was derived from TCGA expression profiling data using the R software package “Estimate” (Yoshihara et al. 2013).”
MethodSun, R., Liu, Y., Sun, Y., Zhou, M., Wang, Y., Shi, B., Jiang, H., & Li, Z. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01287-8 · Cited by 48
“The ESTIMATE algorithm was used to estimate the tumor purity and matrix activity of each sample [25].”
SPP1 macrophages in colorectal cancer: Markers of malignancy and promising therapeutic targets
Xie, Z., Zheng, G., Niu, L., Du, K., Li, R., Dan, H., Duan, L., Wu, H., Ren, G., Dou, X., et al. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101340 · Cited by 51
“61 The immune cell marker CD45 was also used to assess the level of immune cell infiltration in tissues.”
High-throughput genomic profiling of tumor-infiltrating leukocytes
Newman, A. M., & Alizadeh, A. A. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.06.006 · Cited by 49
“To establish baseline performance, we recommend that marker genes (and signature matrices) be validated by analyzing independently generated GEPs of (1) the same leukocyte phenotypes, (2) different leukocyte phenotypes, and (3) samples devoid of immune content.”
BackgroundMethodInfluentialTumor purity quantification by clonal DNA methylation signatures
Benelli, M., Romagnoli, D., & Demichelis, F. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty011 · Cited by 44
Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling
Zou, Q., Xiao, Z., Huang, R., Wang, X., Wang, X., Zhao, H., & Yang, X. (2019) · Theranostics · doi:10.7150/thno.35033 · Cited by 47
“As solid tumors are known for the intra-tumoral heterogeneity, i.e., heterogeneous non-tumor cells infiltrated in the tumor tissues, we used ESTIMATE [14] to assess purities of the 10 HCC tumors with the RNA-seq data.”
MethodTP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival
Freudenstein, D., Litchfield, C., Caramia, F., Wright, G. M., Solomon, B., Ball, D., Keam, S. P., Neeson, P. J., Haupt, Y., & Haupt, S. (2020) · Cancers · doi:10.3390/cancers12061535 · Cited by 53
“The CPE is the median purity estimate from the following methods: ABSOLUTE (a somatic copy-number measure), ESTIMATE (based on expression of a 141 immune gene set and a 141 stromal gene set [61]), LUMP (leukocytes unmethylation for purity that utilizes an average of 44 nonmethylated immune-specific CpG sites), and cel…”
MethodEs, H. A., Zhand, S., Thiery, J. P., & Warkiani, M. E. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa014 · Cited by 46
Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer
Li, N., Shen, J., Qiao, X., Gao, Y., Su, H.-B., & Zhang, S. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s331378 · Cited by 51
Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
Han, J., Yang, Y., Li, X., Wu, J., Sheng, Y., Qiu, J., Wang, Q., Li, J., He, Y., Cheng, L., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13203 · Cited by 46
Grass, G. D., Alfonso, J. C. L., Welsh, E. A., Ahmed, K. A., Teer, J. K., Pilon‐Thomas, S., Harrison, L. B., Cleveland, J. L., Mulé, J. J., Eschrich, S. A., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.03.006 · Cited by 51
Peng, X., Zhu, J., Liu, S., Luo, C. H., Wu, X., Liu, Z., Li, Y., & Yuan, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.990790 · Cited by 49
“This suggests that our DECRGs have the potential to predict the composition of the TME.”
MethodInfluentialLawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 59
Ke, Z., Wu, Y., Huang, P., Hou, J. Y., Chen, Y., Dong, R., Lin, F., Wei, Y., Xue, X., Ng, C., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29898 · Cited by 43
“We then calculated the immune scores by using the ESTIMATE algorithm accordingly (Yoshihara et al., 2013).”
MethodA Novel Classification Model for Lower-Grade Glioma Patients Based on Pyroptosis-Related Genes
Shen, Y., Chi, H., Xu, K., Li, Y., Yin, X., Chen, S., Yang, Q., He, M., Zhu, G., & Li, X. (2022) · Brain Sciences · doi:10.3390/brainsci12060700 · Cited by 49
“We calculated the stromal, immune, and ESTIMATE scores of all samples using the ESTIMATE algorithm [19].”
MethodZhou, B., Bie, F., Zang, R., Zhang, M., Song, P., Liu, L., Peng, Y., Bai, G., Zhao, J., & Gao, S. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104268 · Cited by 45
Zeng, B., Chen, Y., Chen, H. H., Zhao, Q., Sun, Z., Liu, D., Li, X., Zhang, Y., Wang, J., & Xing, H. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106660 · Cited by 46
Cheng, C., Nguyen, T. T., Tang, M., Wang, X., Jiang, C., Liu, Y., Gorlov, I. P., Gorlova, O. Y., Iafrate, J., Lanuti, M. D., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.04.022 · Cited by 52
Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance
Liu, Y., Chen, Y., Wang, F., Lin, J., Tan, X., Chen, C., Wu, L., Zhang, X., Wang, Y., Shi, Y., et al. (2023) · Discover Oncology · doi:10.1007/s12672-023-00765-5 · Cited by 43
“The Estimation of Stromal and Immune Cells in Malignant Tumors using Expression Data (ESTIMATE) is a package which uses gene expression data to predict the content of interstitial cells and immune cells in malignant tumor tissues [22].”
MethodZhang, B., Liu, J., Li, H., Huang, B., Zhang, B., Song, B., Bao, C., Liu, Y., & Wang, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1244752 · Cited by 49
“To analyze the differences in tumour immune microenvironment among different intratumor microbiome subtypes, the stromal, immune, and ESTIMATE score of every PC patient were evaluated utilizing “ESTIMATE” algorithm (Yoshihara et al., 2013).”
MethodYamauchi, M., Ono, A., Amioka, K., Fujii, Y., Nakahara, H., Teraoka, Y., Uchikawa, S., Fujino, H., Nakahara, T., Murakami, E., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00390-x · Cited by 45
“Another established score for quantifying immune cells in the TME, Immune score 26 , also showed a strong correlation with our clustering results (upper column, Fig.”
ResultLi, J., Hu, H., Qin, G., Bai, F., Wu, X., Ke, H., Zhang, J., Xie, Y., Wu, Z., Fu, Y., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2213 · Cited by 43
Han, B., Guan, X., Ma, M., Liang, B., Ren, L., Liu, Y., Du, Y., Jiang, S., & Song, D. E. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00901-x · Cited by 46
“Combining the transcriptome RNAseq data of each BRCA case, we compared the stromal Score and immune score of the BRCA samples with ESTIMATE algo-rithm [27].”
Wang, S., Wu, C., He, M.-M., Yong, J.-X., Chen, Y., Qian, L.-M., Zhang, J., Zeng, Z.-L., Xu, R., Wang, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45479-6 · Cited by 45
“Previous studies have shown tumor purity could in fl uence the analysis of clinical tumor samples and biological interpretation of the results 40,41 .”
Lv, G., Xin, W., Wu, M., Wen-juan, M., Ranyi, L., Zhizhong, P., Rongxin, Z., & Chen, G. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03925-w · Cited by 46
“0 were used to predict the immune infiltration status in TCGA-COAD and TCGA-READ datasets [12, 13].”
Transcriptional dissection of pancreatic tumors engrafted in mice
Martinez-Garcia, R., Juan, D., Rausell, A., Muñoz, M., Baños, N., Menéndez, C., Lopez-Casas, P. P., Rico, D., Valencia, A., & Hidalgo, M. M. (2014) · Genome Medicine · doi:10.1186/gm544 · Cited by 50
“However, when we compared the Y-axis of the expression space generated without the hNTI cell signature genes (Figure 3B) with the ESTIMATE scores, we observed a striking and very A) B) Figure 3 Gene expression from tumor-infiltrating stromal and immun each of the four groups of samples, where a higher score indicates…”
BackgroundMethodInfluentialÁrnadóttir, S. S., Jeppesen, M., Lamy, P., Bramsen, J. B., Nordentoft, I., Knudsen, M., Vang, S., Madsen, M. R., Thastrup, M., Thastrup, J., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12156 · Cited by 47
The Complex Subtype-Dependent Role of Connexin 43 (GJA1) in Breast Cancer
Busby, M., Hallett, M. T., & Plante, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030693 · Cited by 43
“Whole-tumor expression has been used by others, both to assess the content of specific cell types in samples and to decipher functional links between genes [38,39].”
Prasmickaite, L., Tenstad, E. M., Pettersen, S., Jabeen, S., Egeland, E. V., Nord, S., Pandya, A. D., Haugen, M. H., Kristensen, V. N., Børresen‐Dale, A., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12319 · Cited by 45
“Abundance of stroma and immune cells in the samples was inferred from gene expression signatures by ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumors using Expression data; Yoshihara et al., 2013).”
MethodA Multi-Cohort and Multi-Omics Meta-Analysis Framework to Identify Network-Based Gene Signatures
Shafi, A., Nguyen, T., Peyvandipour, A., Nguyen, H., & Drăghici, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00159 · Cited by 47
“Previously, it has been shown by others that a higher tumor purity score is associated with tumor growth, disease progression and drug resistance (Yoshihara et al., 2013).”
BackgroundDecamps, C., Privé, F., Bacher, R., Jost, D., Waguet, A., Houseman, E. A., Lurie, E., Lutsik, P., Milosavljevic, A., Scherer, M., et al. (2020) · BMC Bioinformatics · doi:10.1186/s12859-019-3307-2 · Cited by 48
“We compared the consistency of immune cell (IC) fraction estimated by our pipeline with the IC fraction estimated by the reference-based EpiDISH algorithm [19] and the IC fraction estimated by ESTIMATE algorithm [20] on RNA-seq profiles (Additional file 1: Figure S12 and S13).”
MethodPrognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
Zhang, M., Wang, X., Chen, X., Guo, F., & Hong, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00441 · Cited by 48
Jin, W.-Y., Zhang, Y.-B., Liu, Z., Che, Z.-F., Gao, M., & Peng, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29842 · Cited by 38
“ESTIMATE is a sophisticated algorithm that exploits the unique properties of cancer cell transcriptional profiles to estimate the degree of infiltration of tumor cells and different normal cells (Yoshihara et al., 2013).”
BackgroundKampa, M., Notas, G., Stathopoulos, E. N., Tsapis, A., & Castanas, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00827 · Cited by 46
“However, this result should be interpreted with caution, as the TCGA collection comprises stromal immune cell infiltrates at different proportions, ranging from 5 to >60% (138).”
BackgroundZhang, X., Shao, S., & Li, L. (2020) · Cancers · doi:10.3390/cancers12071816 · Cited by 47
“The ESTIMATE immune score and stromal score were used to analyze the infiltration levels of immune cells and stromal cells in different tumors [52].”
MethodInfluentialXu, F., He, L., Zhan, X., Chen, J., Xu, H., Huang, X., Li, Y., Zheng, X., Lin, L., & Chen, Y. (2020) · Aging · doi:10.18632/aging.104129 · Cited by 54
“RNA sequencing and its clinical LUAD patient data were obtained from the TCGA website.”
MethodInfluentialQiu, H., Li, Y., Cheng, S., Li, J., He, C. H., & Li, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.580263 · Cited by 45
“By analyzing specific gene expression, the algorithm infers the infiltration of stromal and immune cells and assesses tumor purity (18).”
BackgroundMethodBao, D., Zhang, C., Li, L., Wang, H., Li, Q., Ni, L., Lin, Y., Huang, R., Yang, Z., Zhang, Y., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.553297 · Cited by 43
Huang, X., Zhang, F., He, D., Ji, X., Gao, J., Liu, W., Wang, Y., Liu, Q., & Xin, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.646060 · Cited by 48
Winkler, C., King, M., Berthe, J., Ferraioli, D., Garuti, A., Grillo, F., Rodriguez‐Canales, J., Ferrando, L., Chopin, N., Ray-Coquard, I. L., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146098 · Cited by 45
“With this aim, we estimated cancer cellularity in a second HGSOC cohort from TCGA ( n = 302 cases) with ESTIMATE (25), and we inferred leukocyte subpopulations using CIBERSORTx, a well-established method for characterizing the immune cell composition of tissues from their gene expression profiles (26).”
TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas
Chen, R., Wang, X., Dai, Z., Wang, Z., Wu, W., Hu, Z., Zhang, X., Liu, Z., Zhang, H., & Cheng, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713757 · Cited by 45
“TNFSF13 Is Correlated With Infiltrating Immune and Stromal Cells in Glioma Microenvironment Previous molecular research reminded us that considerable cellular components forming tumors play a crucial part in tumor signal and cancer biology, such as infiltrated immune and stromal cells (51).”
BackgroundCheng, X. M., Cao, Y., Wang, X., Cheng, L., Liu, Y., Jun, L., Peng, W., & Shi, D. (2022) · Journal of Immunology Research · doi:10.1155/2022/5254911 · Cited by 48
“We analyzed relevant gene sets (Table S2) from previous studies [23 – 25] and then performed ssGSEA to quantify the immune status of each sample.”
Wu, Q., Wang, L., Wei, H., Li, B., Yang, J., Wang, Z., Xu, J., Zhou, Y. L., & Zhang, B. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106477 · Cited by 60
Pan, S., Sun, S., Liu, B., & Hou, Y. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0013 · Cited by 52
“Stromal and immune infiltration analysis Stromal and immune fractions were evaluated using the Estimation of STromal and Immune cells in MAlignant Tumor tissues using expression data (ESTIMATE) program.[22] Using the estimate.”
MethodZhang, P., Liu, J.-L., Pei, S., Wu, D., Xie, J., Liu, J., & Li, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1189520 · Cited by 48
“Additionally, the R package “estimate” was utilized to determine the immunological scores, stromal scores, and ESTIMATE scores of LUAD patients (25, 26).”
MethodImmunotherapy and Cancer: The Multi-Omics Perspective
Donisi, C., Pretta, A., Pusceddu, V., Ziranu, P., Lai, E., Puzzoni, M., Mariani, S., Massa, E., Madeddu, C., & Scartozzi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063563 · Cited by 46
Weng, Y., Yuan, J., Cui, X., Wang, J., Chen, H., Li, X., Chen, X., Peng, M., & Song, Q. (2024) · Scientific Reports · doi:10.1038/s41598-024-64980-y · Cited by 46
“Infiltration levels of stromal and immune cells can be calculated with the ESTIMATE algorithm 15 .”
MethodChen, Y.-T., Widschwendter, M., & Teschendorff, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1366-0 · Cited by 37
“Indeed, we observed, using the ESTIMATE algorithm [46], that lung is among the epithelial tissues with the highest contamination of immune cells (Additional file 1: Figure S1).”
MethodJang, B., & Kim, I. A. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.05.003 · Cited by 44
Gupta, M. K., Polisetty, R. V., Sharma, R., Ganesh, R. A., Gowda, H., Purohit, A. K., Ankathi, P., Prasad, K., Mariswamappa, K., Lakshmikantha, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47360-9 · Cited by 42
Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network
Liang, Q., Li, X., Guan, G., Xu, X., Chen, C., Cheng, P., Cheng, W., & Wu, A. (2019) · Aging · doi:10.18632/aging.102205 · Cited by 42
“net/ projects/estimateproject/) as previously described [47].”
Kim, J., Yu, D., Kwon, Y., Lee, K. S., Sim, S. H., Kong, S., Lee, E. S., Park, I. H., & Park, C. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0453 · Cited by 44
“The abundance of stromal and immune cells was estimated by the ESTIMATE tool (23).”
MethodAlterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
Li, B., Geng, R., Wu, Q., Yang, Q., Sun, S., Zhu, S., Xu, Z., & Sun, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00333 · Cited by 45
“We calculated immune scores and stromal scores by applying the ESTIMATE algorithm to gene expression data (9).”
MethodInfluentialLeventoux, N., Augustus, M., Azar, S., Riquier, S., Villemin, J.-P., Guelfi, S., Falha, L., Bauchet, L., Gozé, C., Ritchie, W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62145-1 · Cited by 46
Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors
Chen, D., Li, G., Ji, C., Lu, Q., Qi, Y., Tang, C., Xiong, J., HU, J. L., Yasar, F. B. A., Zhang, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000154 · Cited by 44
“25 Samples from TCGA having genomic sequencing data were labeled with ABSOLUTE purity instead of ESTIMATE purity and were extracted from previous paper.”
PDIA3 correlates with clinical malignant features and immune signature in human gliomas
Zhang, H., Zhou, Y., Cheng, Q., Dai, Z., Wang, Z., Liu, F., Fan, F., Cui, B., & Cao, H. (2020) · Aging · doi:10.18632/aging.103601 · Cited by 42
“com 15396 AGING are responsible for cancer biology and tumor signaling [37].”
BackgroundLee, D., Park, Y., & Kim, S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa188 · Cited by 49
Lin, J., Yang, J., Xu, X. L., Wang, Y., Yu, M., & Zhu, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01491-6 · Cited by 45
Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma
Yuan, X., Li, Y., Zhang, A. Z., Jiang, C. H., Li, F. P., Xie, Y., Li, J. F., Liang, W. H., Zhang, H. J., Liu, C. X., et al. (2020) · Aging · doi:10.18632/aging.202201 · Cited by 44
“Tumor purity significantly influences the genomic analysis of immune cell infiltration in clinical tumor samples [20].”
BackgroundChen, Y., Meng, Z., Zhang, L., & Liu, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664845 · Cited by 56
“Identification of TME-Related DEGs DEGs were identified between the high and low ImmuneScore groups and between the high and low StromalScore groups (14).”
BackgroundIdentification of Immune-Related Key Genes in Ovarian Cancer Based on WGCNA
Quan, Q., Xiong, X., Wu, S., & Yu, M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.760225 · Cited by 42
“In this study, the immune score of each sample was calculated by “ESTIMATE” R package (Yoshihara et al., 2013) and the relative abundances of various subtypes of tumor-infiltrating immune cells were defined by CIBERSORT algorithms (Chen et al., 2018) based on the RNA-seq data.”
MethodIntegrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
Ding, J.-H., Xiao, Y., Zhao, S., Xu, Y., Xiao, Y.-L., Shao, Z., Jiang, Y., & Di, G. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.02.003 · Cited by 50
“Stromal scores were calculated by the ESTIMATE algorithm to analyze the infiltration levels of stromal cells in different grades of fibrosis.(59) To investigate CAF subtypes in this cohort, we referred to the CIBERSORTx algorithm to predict the proportion of different kinds of CAF subtypes in each sample based on RNA-…”
MethodZhang, S., Wang, H., Liu, J., Tao, T., Zeng, Z., & Wang, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03526-0 · Cited by 49
“4C) and higher TumorPurity (Fig.”
MethodAmes, J. B., Lurie, J. D., Tomek, I. M., Zhou, W., & Koval, K. J. (2010) · PubMed · Cited by 48
Metadata
- Authors
- Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., Carter, S. L., Getz, G., Stemke-Hale, K., Mills, G. B., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Memorial Sloan Kettering Cancer Center (US)
- Broad Institute (US)
- Corresponding author
- Verhaak, Roel G.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-11
- Volume
- 4
- Issue
- 1
- Pages
- 2612-2612
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3826632
- OpenAlex
- W2130430382
- Cited by
- 9,778
- References
- 63
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 1602 · 2023: 1755 · 2022: 1988 · 2021: 1316 · 2020: 683 · 2019: 223 · 2018: 121 · 2017: 93 · 2016: 53 · 2015: 39 · 2014: 20 · 2013: 2
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (P50CA098258, U24CA143882, CA143883, U24CA143883, P30CA008748, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- tumor purity, tumor stroma, tumor-infiltrating immune cells, gene expression signatures, tumor microenvironment, DNA copy number, cancer transcriptomics
- MeSH terms
- Algorithms, Cell Separation, Female, Humans, Leukocytes, Neoplasms, Research Design, Sensitivity and Specificity, Software, Gene Library, Genome, Human, Stromal Cells, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, DNA Copy Number Variations, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.